SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Feb 27, 2020	Securities offered to employees pursuant to employee benefit plans	S-8	0001737287-20-000013.pdf 0001737287-20-000013.rtf 0001737287-20-000013.xls View HTML
Feb 24, 2020	Statement of changes in beneficial ownership of securities	4	0001214659-20-001733.pdf 0001214659-20-001733.rtf 0001214659-20-001733.xls View HTML
Feb 14, 2020	A statement of beneficial ownership of common stock by certain persons	SC 13G	0001422848-20-000012.pdf 0001422848-20-000012.rtf View HTML
Feb 13, 2020	An amendment to the SC 13G filing	SC 13G/A	0001193125-20-035541.pdf 0001193125-20-035541.rtf 0001193125-20-035541.xls View HTML
Feb 13, 2020	An amendment to the SC 13G filing	SC 13G/A	0001193125-20-035546.pdf 0001193125-20-035546.rtf 0001193125-20-035546.xls View HTML
Dec 20, 2019	Report of unscheduled material events or corporate event	8-K	0001737287-19-000025.pdf 0001737287-19-000025.rtf 0001737287-19-000025.xls View HTML
Nov 21, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-007333.pdf 0001214659-19-007333.rtf View HTML
Nov 21, 2019	Statement of changes in beneficial ownership of securities	4	0001214659-19-007335.pdf 0001214659-19-007335.rtf View HTML
Nov 05, 2019	Report of unscheduled material events or corporate event	8-K	0001737287-19-000016.pdf 0001737287-19-000016.rtf 0001737287-19-000016.xls View HTML
Nov 05, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001737287-19-000020.pdf 0001737287-19-000020.rtf 0001737287-19-000020.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.